- TWD3.04bn
- TWD2.52bn
- TWD222.88m
- 78
- 11
- 62
- 50
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 5.32 | ||
Price to Tang. Book | 5.48 | ||
Price to Free Cashflow | 44 | ||
Price to Sales | 13.64 | ||
EV to EBITDA | 34.67 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 10.54% | ||
Return on Equity | 16.09% | ||
Operating Margin | 27.35% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | TWDm | 26.59 | 56.3 | 106.27 | 159.64 | 222.88 | n/a | n/a | 70.15% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | +1419.78 | +163.64 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Bonraybio Co Ltd is a Taiwan-based company mainly engaged in the research and development of sperm testing systems. The Company provides products include sperm quality analysis testers, sperm testing reagents, sperm deoxyribonucleic acid (DNA) debris testing reagent sets, sperm optimizers, and other products including quality control testing kits, sperm collection cups, and cleaning swabs. The Company markets its products worldwide.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 12th, 2016
- Public Since
- July 25th, 2023
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Taiwan Stock Exchange
- Shares in Issue
- 21,566,000

- Address
- 4F, TAICHUNG, 412
- Web
- https://www.bonraybio.com/
- Phone
- +886 424912385
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for 6955
Similar to 6955
Apex Biotechnology
Taiwan Stock Exchange
Wellell
Taiwan Stock Exchange
Bionime
Taiwan Stock Exchange
CHC Healthcare
Taiwan Stock Exchange
Excelsior Medical Co
Taiwan Stock Exchange
FAQ
As of Today at 19:40 UTC, shares in Bonraybio Co are trading at TWD141.00. This share price information is delayed by 15 minutes.
Shares in Bonraybio Co last closed at TWD141.00 and the price had moved by +2.63% over the past 365 days. In terms of relative price strength the Bonraybio Co share price has outperformed the FTSE Developed Asia Pacific Index by +3.8% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Bonraybio Co dividend yield is 1.06% based on the trailing twelve month period.
Last year, Bonraybio Co paid a total dividend of TWD1.50, and it currently has a trailing dividend yield of 1.06%. We do not have any data on when Bonraybio Co is to next pay dividends.
We do not have data on when Bonraybio Co is to next pay dividends. The historic dividend yield on Bonraybio Co shares is currently 1.06%.
To buy shares in Bonraybio Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of TWD141.00, shares in Bonraybio Co had a market capitalisation of TWD3.04bn.
Here are the trading details for Bonraybio Co:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 6955
Based on an overall assessment of its quality, value and momentum Bonraybio Co is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bonraybio Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +2.69%.
As of the last closing price of TWD141.00, shares in Bonraybio Co were trading -1.1% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bonraybio Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD141.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Bonraybio Co's directors